[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)]
[Notices]
[Page 58478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24656]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Committee on Immunization Practices 
(ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee.

Time and Date: 8:00 a.m.-6:00 p.m., EDT, October 21, 2015.

Place:  CDC, Tom Harkin Global Communications Center, 1600 Clifton Road 
NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia 
30329.

Status:  Open to the public, limited only by the space available. Time 
will be available for public comment. The public is welcome to submit 
written comments in advance of the meeting. Comments should be 
submitted in writing by email to the contact person listed below. The 
deadline for receipt October 12, 2015. All requests must contain the 
name, address, and organizational affiliation of the speaker, as well 
as the topic being addressed. Written comments should not exceed one 
single-spaced typed page in length and delivered in 3 minutes or less. 
Please note that the public comment period may end before the time 
indicated, following the last call for comments. Members of the public 
who wish to provide public comments should plan to attend the public 
comment session at the start time listed. Written comments received in 
advance of the meeting will be included in the official record of the 
meeting.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.

Purpose:  The committee is charged with advising the Director, CDC, on 
the appropriate use of immunizing agents. In addition, under 42 U.S.C. 
1396s, the committee is mandated to establish and periodically review 
and, as appropriate, revise the list of vaccines for administration to 
vaccine-eligible children through the Vaccines for Children (VFC) 
program, along with schedules regarding the appropriate periodicity, 
dosage, and contraindications applicable to the vaccines. Further, 
under provisions of the Affordable Care Act, at section 2713 of the 
Public Health Service Act, immunization recommendations of the ACIP 
that have been adopted by the Director of the Centers for Disease 
Control and Prevention and appear on the CDC immunization schedules 
must be covered by applicable health plans.

Matters For Discussion:  The agenda will include discussions on: child 
and adolescent immunization schedule; adult immunization schedule; 
meningococcal vaccines; human papillomavirus vaccines; influenza; 
combination vaccine (pediatric hexavalent vaccine (DTaP-IPV-Hib-HepB); 
cholera vaccine; Japanese encephalitis vaccine; Ebola vaccine trial 
update and vaccine supply. Recommendation votes are scheduled for child 
and adolescent immunization schedule and adult immunization schedule.
    Agenda items are subject to change as priorities dictate.

Contact Person For More Information:  Stephanie Thomas, National Center 
for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE., 
MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; Email 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 2015-24656 Filed 9-28-15; 8:45 am]
 BILLING CODE 4163-18-P